The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 04, 2023
Filed:
Oct. 16, 2014
Applicant:
Brigham Young University, Provo, UT (US);
Inventors:
Paul B. Savage, Mapleton, UT (US);
Carl A. Genberg, Las Vegas, NV (US);
Michael D. Triplett, New Albany, OH (US);
Assignee:
Brigham Young University, Provo, UT (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/575 (2006.01); A61K 45/06 (2006.01); A61K 38/14 (2006.01); A61K 31/7052 (2006.01); A61K 38/12 (2006.01); A61K 31/427 (2006.01); A61K 31/7036 (2006.01); A61K 31/7048 (2006.01); A61K 31/496 (2006.01); A61K 38/06 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/575 (2013.01); A61K 9/0078 (2013.01); A61K 31/427 (2013.01); A61K 31/496 (2013.01); A61K 31/7036 (2013.01); A61K 31/7048 (2013.01); A61K 31/7052 (2013.01); A61K 38/06 (2013.01); A61K 38/12 (2013.01); A61K 38/14 (2013.01); A61K 45/06 (2013.01);
Abstract
Methods of treating, reducing, or preventing lung infections or lung inflammation include identifying a patient in need of treatment and administering a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA), or a pharmaceutically acceptable salt thereof. Treatment of cystic fibrosis lung infections, COPD lung infections, inflammation of the lungs in these patient populations, and lung scarring in these patient populations is also described.